AyoxxA Biosystems GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AyoxxA Biosystems GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11207
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AyoxxA Biosystems GmbH (AyoxxA) is a life science tools company that provides protein analysis solutions. The company offers multiple detection kits, cytokine detection kits, human inflammation kits, mouse inflammation kits, and human opthalmology kits. Its services include complete testing services, biochip readout services, biomarker screening, selection and validation, custom panel configuration, and custom multiplex assay development. AyoxxA’s products are used in the analysis of serum, cell culture supernatant, ocular disorders, aqueous humor and vitreous humor matrices. The company markets its products through a network of distributors in Germany, Singapore and the US markets. AyoxxA is headquartered in Koln, Germany.

AyoxxA Biosystems GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AyoxxA Biosystems GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 11
Ayoxxa Biosystems Raises USD12 Million in Series B Financing 12
AyoxxA Biosystems Raises US$0.5 Million In Second Tranche Of Series A Financing 14
AyoxxA Biosystems Raises USD3.4 Million in Series A Financing 16
Partnerships 17
Ayoxxa Biosystems Completes Research Collaboration With Grunenthal 17
Ayoxxa Biosystems Enters Into Research Agreement With NUS For Protein Analysis Technology Development 18
AyoxxA Biosystems GmbH – Key Competitors 19
AyoxxA Biosystems GmbH – Key Employees 20
AyoxxA Biosystems GmbH – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Product News 22
Dec 05, 2017: AYOXXA Launches LUNARIS Human 11-Plex Ophthalmology Kit 22
Apr 18, 2018: AYOXXA launches LUNARIS Human 12-Plex Th17 Kit expanding its portfolio for fully scalable biomarker analysis 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Key Facts 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AyoxxA Biosystems GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
AyoxxA Biosystems GmbH, Medical Devices Deals, 2012 to YTD 2018 9
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 11
Ayoxxa Biosystems Raises USD12 Million in Series B Financing 12
AyoxxA Biosystems Raises US$0.5 Million In Second Tranche Of Series A Financing 14
AyoxxA Biosystems Raises USD3.4 Million in Series A Financing 16
Ayoxxa Biosystems Completes Research Collaboration With Grunenthal 17
Ayoxxa Biosystems Enters Into Research Agreement With NUS For Protein Analysis Technology Development 18
AyoxxA Biosystems GmbH, Key Competitors 19
AyoxxA Biosystems GmbH, Key Employees 20
AyoxxA Biosystems GmbH, Subsidiaries 21

List of Figures
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AyoxxA Biosystems GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AyoxxA Biosystems GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AyoxxA Biosystems GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Patterson-UTI Energy Inc (PTEN):企業の財務・戦略的SWOT分析
    Patterson-UTI Energy Inc (PTEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Oncolys BioPharma Inc (4588)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolys BioPharma Inc (Oncolys) is a biotechnology company that discovers, and develops treatments for cancer and infectious diseases. The company imports and exports oncolytic viruses, drugs and medicines, and tumor diagnostic agents. Its pharmaceutical pipeline products include OBP-301, OB …
  • Microsoft Corporation:企業のM&A・事業提携・投資動向
    Microsoft Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Microsoft Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Accenture plc:企業のM&A・事業提携・投資動向
    Accenture plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Accenture plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Oxford Biodynamics Plc-医療機器分野:企業M&A・提携分析
    Summary Oxford Biodynamics Plc (Oxford Biodynamics) is a biotechnology company that discovers and develops biomarker discovery platform. The company concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression such as oncology, metabolic, …
  • Texas Children’s Hospital:企業の戦略的SWOT分析
    Texas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • NGK Spark Plug Co Ltd:戦略・SWOT・企業財務分析
    NGK Spark Plug Co Ltd - Strategy, SWOT and Corporate Finance Report Summary NGK Spark Plug Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Coppermoly Limited:企業の戦略・SWOT・財務情報
    Coppermoly Limited - Strategy, SWOT and Corporate Finance Report Summary Coppermoly Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Orpak Systems Limited:企業の戦略的SWOT分析
    Orpak Systems Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Imagination Technologies Group plc:企業のM&A・事業提携・投資動向
    Imagination Technologies Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Imagination Technologies Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Aeon Global Health Corp (ADAT)-医療機器分野:企業M&A・提携分析
    Summary Aeon Global Health Corp (Aeon), formerly Authentidate Holding Corp is a clinical lab and healthcare services organization that offers diagnostic services in cancer genomics, toxicology, pharmacogenomics, and health technology applications. The organization offers clinical laboratory services …
  • Alchemia Ltd (ACL)-製薬・医療分野:企業M&A・提携分析
    Summary Alchemia Ltd (Alchemia) is a biopharmaceutical company that focuses on the discovery and development of drugs for the treatment of cancer and respiratory disorders. It sold the worldwide exclusive intellectual property rights to its product, Fondaparinux sodium (a generic version of the anti …
  • Novo Nordisk AS (NOVO B)-医療機器分野:企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Melinta Therapeutics Inc (MLNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Melinta Therapeutics Inc (Melinta) is a biopharmaceutical company that focuses on the development of novel antibiotics. Its drugs are intended to treat the various bacterial infections. The company's lead product Baxdela (delafloxacin) has been approved by the US FDA as an IV treatment for s …
  • Ricardo plc:企業の戦略・SWOT・財務情報
    Ricardo plc - Strategy, SWOT and Corporate Finance Report Summary Ricardo plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Meiji Holdings Co, Ltd.
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PLx Pharma Inc (PLXP)-製薬・医療分野:企業M&A・提携分析
    Summary PLx Pharma Inc (PLx Pharma) is a drug development company that develops patent-protected delivery systems. The company’s products include PLxGuard delivery system, PLxGuard pipeline products, PL2200 aspirin and PL1100 and PL1200 ibuprofen products. Its PLxGuard delivery system are used in en …
  • Dohler GmbH:企業の戦略・SWOT・財務分析
    Dohler GmbH - Strategy, SWOT and Corporate Finance Report Summary Dohler GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • SONIFI Solutions, Inc:企業の戦略的SWOT分析
    SONIFI Solutions, Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • High Energy Batteries (India) Ltd
    High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary High Energy Batteries (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆